Vireo Growth (VREOD) Stock Price, News & Analysis
Company Description
Vireo Growth (OTC Link: VREOD) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $490.7M.
For FY2025, Vireo Growth reported revenue of $268.8M with net income of -$68.1M and diluted earnings per share of $-0.09. The company operates at a net profit margin of -25.3%.
This page collects what Stock Titan holds for VREOD, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Vireo Growth (VREOD) stock last closed at $9.95. At a market capitalization of $490.7M, VREOD is classified as a small-cap stock with approximately 49.3M shares outstanding.
VREOD Rankings
Latest News
Vireo Growth has 8 recent news articles, with the latest published 2 days ago. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include earnings date, acquisition. View all VREOD news →
SEC Filings
Vireo Growth has filed 4 recent SEC filings, including 2 Form 4, 1 Form 8-K/A, 1 Form 8-K. The most recent filing was submitted on June 18, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all VREOD SEC filings →
Financial Highlights
Vireo Growth generated $268.8M in revenue in FY2025, retaining a 47.3% gross margin, operating income reached -$1.0M (-0.4% operating margin), and net income was -$68.1M, reflecting a -25.3% net profit margin. Diluted earnings per share stood at $-0.09. The company generated $3.7M in operating cash flow. With a current ratio of 1.59, the balance sheet reflects a strong liquidity position.
Upcoming Events
VREO share issuance
Vireo Growth has 1 upcoming scheduled event. The next event, "VREO share issuance", is scheduled for July 17, 2028 (in 711 days). 1 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the VREOD stock price.
Short Interest History
Short interest in Vireo Growth (VREOD) currently stands at 2 shares, down 97.8% from the previous reporting period. Since June 2026, short interest has decreased by 97.8%.
Days to Cover History
Days to cover for Vireo Growth (VREOD) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
VREOD Company Profile & Sector Positioning
Vireo Growth (VREOD) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.